Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
22.49M | 27.68M | 22.12M | 19.52M | 11.45M | 3.71M | Gross Profit |
511.72K | 2.46M | 1.26M | 1.99M | 1.07M | 220.42K | EBIT |
-3.44M | -5.81M | -7.27M | -4.85M | -2.53M | -2.29M | EBITDA |
-3.59M | -9.19M | -9.25M | -5.32M | -6.55M | -2.36M | Net Income Common Stockholders |
-7.85M | -13.43M | -10.83M | -6.34M | -7.05M | 10.41K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
189.02K | 195.04K | 5.86M | 11.87M | 4.13M | 54.56K | Total Assets |
3.34M | 6.92M | 11.37M | 20.96M | 6.77M | 2.73M | Total Debt |
1.20M | 12.21M | 8.98M | 8.44M | 4.15M | 1.77M | Net Debt |
1.01M | 12.02M | 3.21M | -3.43M | 20.80K | 1.72M | Total Liabilities |
4.04M | 22.45M | 14.53M | 14.27M | 7.01M | 4.54M | Stockholders Equity |
-698.83K | -15.54M | -3.16M | 6.69M | -237.91K | -1.81M |
Cash Flow | Free Cash Flow | ||||
-1.54M | -3.91M | -5.84M | -5.92M | -1.99M | -1.88M | Operating Cash Flow |
-1.54M | -3.89M | -5.72M | -5.92M | -1.99M | -1.88M | Investing Cash Flow |
-37.50K | -318.38K | -928.58K | -357.41K | 0.00 | 319.56K | Financing Cash Flow |
2.08M | -1.39M | -312.04K | 13.99M | 6.22M | 1.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $36.10B | 39.49 | 2.72% | 4.25% | -13.24% | -65.53% | |
63 Neutral | $20.77B | 13.59 | -10.67% | 7.41% | 1.48% | 9.07% | |
47 Neutral | $179.23M | ― | -18.27% | ― | 7.33% | 84.41% | |
36 Underperform | C$2.16M | ― | 57.30% | ― | -16.50% | 34.47% | |
32 Underperform | $290.12M | ― | -84.50% | ― | -16.27% | 76.17% |
Organto Foods Inc. has announced the revocation of a Cease Trade Order by the British Columbia Securities Commission, allowing the resumption of trading its securities in Canada. The order was initially issued due to the company’s failure to file necessary financial documents, which have since been submitted. Organto is now working to reinstate trading of its shares on the TSX Venture Exchange.
Organto Foods Inc. has announced the resignation of Jeremy Kendall from its Board of Directors, citing personal reasons. This change leaves the board with six members, maintaining a majority of independent directors. Organto continues to focus on providing organic and non-GMO fruits and vegetables globally, aligning with sustainable practices.
Organto Foods has reported a successful third quarter for 2024, highlighting a 47% increase in sales and a 63% rise in gross profit compared to the previous year. The company attributes these positive results to operational restructuring efforts aimed at streamlining costs and improving marketing strategies. Organto remains focused on further growth and financial flexibility, anticipating continued improvements in future quarters.
Organto Foods Inc. has released its fiscal 2024 second-quarter financial results, showing significant improvements as the company restructures its operations and balance sheet for future growth. The firm is focusing on streamlining its product portfolio and reducing operating costs to achieve profitability and long-term stability. Organto is also taking steps to lift its current Cease Trade Order and aims to meet upcoming financial filing deadlines.